Pancreatic Cancer Charity-funded

Pancreatic Cancer UK

Research funded by Pancreatic Cancer UK

Funded awards
52
Published funding
£6.1M
Average published award
£118K
Active funded awards
0
Search funded awards from Pancreatic Cancer UK →

Pancreatic Cancer UK funds most in Cancer — 45 grants (87%). Its largest recipient is Institute of Cancer Research, with 5 grants.

Funded Awards by Year

View data table
YearFunded awards
20103
20112
20137
20147
201512
20168
20175
20183
20195

Grants

Developing advanced CAR-T cell-based immunotherapies to improve the outcome of patients with pancreatic cancerBarts Cancer InstitutePancreatic Cancer UK£995K2017Completed
ADEPTS: Accelerated Diagnosis of neuroEndocrine and Pancreatic TumourSUniversity College LondonPancreatic Cancer UK£762K2018Completed
Creating a rapid diagnostic pathway for patients with pancreatic cancerUniversity College LondonPancreatic Cancer UK£290K2014Completed
Evaluating and combining serum biomarkers for early pancreatic cancer detectionUniversity of LiverpoolPancreatic Cancer UK£150K2011Completed
Exploitation of the initiation of DNA replication for the treatment of pancreatic cancerUniversity College LondonPancreatic Cancer UK£140K2011Completed
The ‘Collins Pancreatic Cancer UK ScholarshipUniversity of ManchesterPancreatic Cancer UK£137K2015Completed
Novel Biomarker discovery for the early detection of pancreatic cancerCold Springs Harbour LaboratoryPancreatic Cancer UK£125K2010Completed
Novel combination therapeutic approaches in pancreatic cancerUniversity of CambridgePancreatic Cancer UK£119K2015Completed
EuropacUniversity of LiverpoolPancreatic Cancer UK£111K2017Completed
Counteracting immune evasion in DNA repair-deficient pancreatic cancers for immunotherapyUniversity of CambridgePancreatic Cancer UK£110K2019Completed
Defining basic properties of oncolytic viral therapy and therapeutic ultrasound co-treatments in pancreatic cancer.Institute of Cancer ResearchPancreatic Cancer UK£110K2019Completed
Targeting autophagy dependence in pancreatic cancerUniversity College LondonPancreatic Cancer UK£109K2019Completed
Metabolic and Immunological Phenotyping in Patients with Pancreatic AdenocarcinomaUniversity of CambridgePancreatic Cancer UK£108K2019Completed
PRECISE: PancREatic Cancer: Individualised Supervised Exercise: a feasibility studyQueen's University BelfastPancreatic Cancer UK£108K2019Completed
Nutritional Therapy When it is NeededChristie NHS Foundation Trust, ManchesterPancreatic Cancer UK£104K2018Completed
Integrating molecular and metabolic profiles to identify subtype-specific therapies in pancreatic ductal adenocarcinomaInstitute of Cancer ResearchPancreatic Cancer UK£100K2015Completed
The correlation of epithelial-mesenchymal transition (EMT) and immunosuppression, and its impact on the response to treatment in pancreatic cancerUniversity of OxfordPancreatic Cancer UK£100K2016Completed
The interplay between c-Met and autophagy in pancreatic ductal adenocarcinoma.Barts, QMULPancreatic Cancer UK£100K2015Completed
Testing genotype-guided therapies in pancreatic cancerUniversity of GlasgowPancreatic Cancer UK£100K2015Completed
Immunotherapy of pancreatic cancer using chimeric antigen receptor engrafted T-cells targeted against the avBeta6 integrinKing's College LondonPancreatic Cancer UK£76K2013Completed

Page 1 of 3